Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,982 public trials 1,832 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

NCT03719105

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations: University of Alabama Birmingham, Alabama, United States

Children's Hospital Orange County Orange, California, United States

University of California San Francisco San Francisco, California, United States

Helen De Vos Grand Rapids, Michigan, United States

View Trial Details

Recruiting

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

NCT06343311

Conditions: B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
Locations: University of California, Davis Sacramento, California, United States

Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States

View Trial Details

Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

A Phase I Dose Finding Study of MB-CART2219.1

NCT07108868

Conditions: Acute Lymphoblastic Leukemia, Pediatric, CLL, Hematologic Diseases, +11 more
Locations: University Hospital , Department of Internal Medicine II Tübingen, Baden-Wurttemberg, Germany

University Hospital, Clinic for Pediatric Medicine Tübingen, Baden-Wurttemberg, Germany

View Trial Details

Recruiting

Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).

NCT06213636

Conditions: Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, in Relapse, Central Nervous System Lymphoma, +19 more
Locations: District One Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL

NCT05554939

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: School of phamaceutical, Tsinghua University Beijing, Beijing Municipality, China

Biotherapeutic Department, Chinese PLA General Hospital Beijing, China

View Trial Details

Recruiting

Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib

NCT06812715

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

Alfred Hospital Melbourne, Victoria, Australia

Monash Medical Centre Melbourne, Victoria, Australia

View Trial Details

Recruiting

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

NCT04440267

Conditions: Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: HBDH Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL

NCT07106723

Conditions: CD7 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

NCT07106749

Conditions: Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, +20 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions